Cochlear is an Australian medical-device company, the pioneer of the cochlear implant (hearing implant). It develops and supplies the implanted device and external processor so people with severe-to-profound hearing loss can regain sound and speech. Research shows cochlear implants greatly raise workplace satisfaction, confidence and social participation. Yet the share of profoundly deaf people using a cochlear implant is under 20% even in high-income countries and about 2.5% worldwide, leaving large room for access. In 2025 the World Health Assembly adopted a resolution on hearing loss, raising the need to integrate hearing care into universal health coverage.
B
NARRATIVE VALUE
Certainty
●●● high
●●● high
ABCDEFG
There is no confirmed −; independently verified + decide the position (B). No unreachable strike-through.= non-additive meter
As of: 2026-Q3Status: ActiveCeiling reason: No confirmed −
History2026-Q3BHistory grows each quarter
Cochlear: Restoring hearing—the pioneer of the cochlear implant. The letter is B; certainty is high. Unconfirmed concerns are placed under “Watching.” (As of 2026-Q3; estimate based on public information.)
Main narrative
One person’s story (N1)
+ A single story
People with severe-to-profound hearing loss whom sound and speech never reach. With Cochlear's implant, they can regain hearing, work, and connect with others. The effect is measured: research shows cochlear implants greatly raise workplace satisfaction, confidence and social participation.
Source nature: P2 Independent (peer-reviewed). Positive effects are not used to offset negatives.
Positive / negative effects
+ effects
- Cochlear-implant use among the profoundly deaf is under 20% even in high-income countries and about 2.5% worldwide—the 2025 WHO resolution pushes integrating hearing care into UHC.P2 Independent (peer-reviewed / WHO)
− effects (confirmed)
- No confirmed −.
Watching (unconfirmed; not counted in the assessment)
- The Deaf-culture/identity debate over cochlear implants (respect for the person's own choice)
- access equity given high cost and low uptake
- a listed, for-profit device maker.
Looking ahead (not included in the assessment)
- Improving access equity (high cost, low uptake); reaching low- and middle-income countries; respecting Deaf culture and personal choice; balancing early intervention with language access.
A second look
The plus is an effect on people with severe-to-profound hearing loss—restored hearing, and the resulting work, confidence and social participation (People)—backed by peer-reviewed research on quality-of-life effects. Caveats: there is a debate between viewing the implant as 'restoring hearing' and the Deaf-culture view of deafness as culture and identity (respect for the person's own choice), and access equity is a challenge given the high cost and low uptake even in high-income countries. It is also a listed, for-profit device maker. Weighing the genuine, verified plus of restored hearing, B/high.
Sources
+N1Impact of Cochlear Implantation on Patients' Working Life｜2024｜🔗
+ effectTrends in Adult Cochlear Implant Access and Uptake｜2025｜🔗
How to read this assessment
A Independently verified +, with no confirmed −
B Leans +, with independent backing
C Mixed. A confirmed − sets the ceiling, or much is unverified
D A serious confirmed − sets the ceiling
E A serious − reaches the core of the organization
F Serious and systemic, with little redeeming +
G Only extreme cases
Out of scope An entity whose core purpose is illegal
On hold Independent evidence is scarce on both + and −
- Reachable upper bound (ceiling): a confirmed − sets the ceiling, and independently verified + decide the position within it. + do not cancel out −.
- The weight of evidence is not symmetric: only confirmed − are counted; the volume of disputes or allegations goes under “Watching.” + are counted from independent evidence, while an organization’s own PR is treated as “reference.”
- Size is not value: scale is not used in the assessment. Matters that stay within money or competition—investors, shareholders, sanctions, trade secrets—are also excluded.
- The letter (assessment) and certainty (how reliable the information is) are separate axes.
This is a translation; the Japanese version is authoritative. The assessments here are generated automatically by AI based on published criteria. The operator does not alter individual results. Because they are AI-generated they may contain errors, and they are opinion and commentary, not statements of fact. Where evidence is insufficient, the entry is marked “On hold.” Requests for correction are accepted via the form.
Terms: Narrative Value = an assessment (A–G) of the distance between the narrative an organization tells and its reality / Ceiling meter = a visualization of the reachable upper bound / Watching = unconfirmed matters not counted / Protected stakeholders = people, animals, nature, and future generations. | Generated by: AI | As of: 2026-Q3 | Back to top